2nd Quarter - Report
WILLIAMS AND JENSEN, PLLC for PHRMA
Client
Income
$30,000
Expenses
—
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Issues relating to drug shortages. Reauthorization of the Prescription Drug User Fee Act (FDA Safety and Innovation Act (S. 3187))
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
| JOEL OSWALD New | Prof. Staff, Senate Banking; LA Sen. Enzi |
Medicare/Medicaid MMM
Medicare payment issues including the Independent Payment Advisory Board (IPAB), and Medicaid issues. Non-interference. Rebates for Medicare Part D. Importation. PDUFA.
| Lobbyist | Covered position, as disclosed |
|---|---|
| JACK STEVEN HART | — |
| SUSAN HIRSCHMANN | — |
| MATTHEW B HOEKSTRA | — |
| KARINA LYNCH | — |
| ERIN BOOK MULLEN | — |
| GEORGE OLSEN | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.